These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10326078)

  • 1. Bootstrapping: estimating confidence intervals for cost-effectiveness ratios.
    Campbell MK; Torgerson DJ
    QJM; 1999 Mar; 92(3):177-82. PubMed ID: 10326078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
    Willan AR; O'Brien BJ
    Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation.
    Briggs AH; Mooney CZ; Wonderling DE
    Stat Med; 1999 Dec; 18(23):3245-62. PubMed ID: 10602149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.
    Chaudhary MA; Stearns SC
    Stat Med; 1996 Jul; 15(13):1447-58. PubMed ID: 8841654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power and sample size calculations for stochastic cost-effectiveness analysis.
    Briggs AH; Gray AM
    Med Decis Making; 1998; 18(2 Suppl):S81-92. PubMed ID: 9566469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confidence intervals for cost-effectiveness ratios: the use of 'bootstrapping'.
    Campbell M; Torgerson D
    J Health Serv Res Policy; 1997 Oct; 2(4):253-5. PubMed ID: 10182254
    [No Abstract]   [Full Text] [Related]  

  • 7. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane.
    Briggs A; Fenn P
    Health Econ; 1998 Dec; 7(8):723-40. PubMed ID: 9890333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical inference for cost-effectiveness ratios.
    Laska EM; Meisner M; Siegel C
    Health Econ; 1997; 6(3):229-42. PubMed ID: 9226141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
    Doshi JA; Glick HA; Polsky D
    Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an angular transformation for ratio estimation in cost-effectiveness analysis.
    Cook JR; Heyse JF
    Stat Med; 2000 Nov; 19(21):2989-3003. PubMed ID: 11042628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confidence intervals for cost-effectiveness ratios: a comparison of four methods.
    Polsky D; Glick HA; Willke R; Schulman K
    Health Econ; 1997; 6(3):243-52. PubMed ID: 9226142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on confidence intervals for incremental cost-effectiveness ratios.
    Wang H; Zhao H
    Biom J; 2008 Aug; 50(4):505-14. PubMed ID: 18663759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confidence intervals for cost/effectiveness ratios.
    Wakker P; Klaassen MP
    Health Econ; 1995; 4(5):373-81. PubMed ID: 8563835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.
    Stinnett AA; Mullahy J
    Med Decis Making; 1998; 18(2 Suppl):S68-80. PubMed ID: 9566468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-parametric methods for cost-effectiveness analysis: the central limit theorem and the bootstrap compared.
    Nixon RM; Wonderling D; Grieve RD
    Health Econ; 2010 Mar; 19(3):316-33. PubMed ID: 19378353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of confidence intervals and sample size calculations in health economic studies.
    Sacristán JA; Day SJ; Navarro O; Ramos J; Hernández JM
    Ann Pharmacother; 1995; 29(7-8):719-25. PubMed ID: 8520090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.
    Blomqvist N
    Stat Med; 1998 Feb; 17(4):503. PubMed ID: 9496725
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
    Wang H; Zhao H
    Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.